{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:39:33Z","timestamp":1761745173456,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00271","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T04:52:41Z","timestamp":1582606361000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy"],"prefix":"10.3389","volume":"11","author":[{"given":"Marta","family":"Grau-Vorster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"L\u00f3pez-Monta\u00f1\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Cant\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Vives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Oliver-Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere","family":"Barba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Querol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Rudilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.bbmt.2018.08.024","article-title":"Establishment and operation of a third party virus-specific T-cell bank within an allogeneic stem cell transplant program","volume":"24","author":"Withers","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.bbmt.2013.07.015","article-title":"CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome","volume":"19","author":"Sukdolak","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2334-7-71","article-title":"Incidence of cytomegalovirus infection among the general population and pregnant women in the United States","volume":"7","author":"Colugnati","year":"2007","journal-title":"BMC Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.bmt.1705906","article-title":"Adoptive cellular immunotherapy for viral diseases","volume":"41","author":"Fujita","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bcmd.2007.07.003","article-title":"Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells","volume":"40","author":"Mackinnon","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1038\/cti.2014.31","article-title":"Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS immune cell serum replacement","volume":"4","author":"Smith","year":"2015","journal-title":"Clin Transl Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/mt.2013.151","article-title":"Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant","volume":"21","author":"Gerdemann","year":"2013","journal-title":"Mol Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/bmt.2014.227","article-title":"A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent","volume":"50","author":"Scarisbrick","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3389\/fimmu.2017.01272","article-title":"Virus-specific T cells for the immunocompromised patient","volume":"8","author":"Houghtelin","year":"2017","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA \u2013 peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J Exp Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1182\/blood.V98.3.754","article-title":"Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers","volume":"98","author":"Gamadia","year":"2001","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/bmt.2008.403","article-title":"Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT","volume":"43","author":"Pourgheysari","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"8243","DOI":"10.4049\/jimmunol.179.12.8243","article-title":"CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses","volume":"179","author":"Novy","year":"2007","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1182\/blood.V98.3.505","article-title":"Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers","volume":"98","author":"Szmania","year":"2001","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00262-010-0871-8","article-title":"WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer","volume":"59","author":"Krug","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/MT.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10616-017-0186-0","article-title":"Optimisation of a potency assay for the assessment of immunomodulative potential of clinical grade multipotent mesenchymal stromal cells","volume":"70","author":"Oliver-Vila","year":"2018","journal-title":"Cytotechnology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1189\/jlb.2A1216-526R","article-title":"Up-regulation of EP 2 and EP 3 receptors in human tolerogenic dendritic cells boosts the immunosuppressive activity of PGE 2","volume":"102","author":"Fl\u00f3rez-Grau","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3.11.1","DOI":"10.1002\/cpim.38","article-title":"Induction and measurement of cytotoxic T lymphocyte activity","volume":"120","author":"Wonderlich","year":"2018","journal-title":"Curr Protoc Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1158\/0008-5472.CAN-07-0321","article-title":"Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system","volume":"67","author":"Berraondo","year":"2007","journal-title":"Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1838","DOI":"10.21769\/BioProtoc.1838","article-title":"In vivo OVA-specific cytotoxic CD8+ T cell killing assay","volume":"6","author":"Chaoul","year":"2016","journal-title":"Bio-protocol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation Methods","volume":"121","author":"Leen","year":"2014","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1182\/blood-2010-04-281873","article-title":"Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes","volume":"116","author":"Barker","year":"2010","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00002371-200407000-00007","article-title":"Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of Epstein-Barr virus-associated diseases","volume":"27","author":"Wilkie","year":"2004","journal-title":"J Immunother"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood."},{"key":"B32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-014-0336-5","article-title":"Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells","volume":"12","author":"Tischer","year":"2014","journal-title":"J Transl Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.bbmt.2015.05.015","article-title":"Immunotherapy with donor T cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia","volume":"21","author":"Koehne","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":"Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells","volume":"201","author":"Bunde","year":"2005","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1182\/bloodadvances.2019000371","article-title":"Mini bank of only 8 donors supplies CMV-directed T cells to diverse recipients","volume":"3","author":"Tzannou","year":"2019","journal-title":"Blood Adv."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1016\/j.celrep.2016.08.065","article-title":"Overcoming CD4 Th1 cell fate restrictions to sustain antiviral CD8 T cells and control persistent virus infection","volume":"16","author":"Snell","year":"2016","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1074-7613(04)00054-8","article-title":"Functional impairment of CD8+T cells by regulatory T cells during persistent retroviral infection","volume":"20","author":"Dittmer","year":"2004","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3324\/haematol.2010.037481","article-title":"Alloreactive and leukemia-reactive T cells are preferentially derived from na\u00efve precursors in healthy donors: implications for immunotherapy with memory T cells","volume":"96","author":"Distler","year":"2011","journal-title":"Haematologica"},{"key":"B39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, epstein-barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"ec42","DOI":"10.1126\/scisignal.2002929","article-title":"Polyfunctional T cells","volume":"5","author":"Foley","year":"2012","journal-title":"Sci Signal"},{"key":"B43","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/blood-2003-03-0824","article-title":"Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles","volume":"103","author":"Kondo","year":"2004","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1479-5876-5-17","article-title":"CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects","volume":"5","author":"Slezak","year":"2007","journal-title":"J Transl Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fimmu.2019.00655","article-title":"Comprehensive evaluation of the expressed CD8+ T cell epitope space using high-throughput epitope mapping","volume":"10","author":"Lehmann","year":"2019","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T04:52:43Z","timestamp":1582606363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2020.00271"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00271","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"article-number":"271"}}